Biostatistics in Clinical Trials
Biostatistics in Clinical Trials
Out of stock
DescriptionThe second volume in the Wiley reference series in Biostatistics.
Featuring articles from the prestigious Encyclopedia of Biostatistics, many of which have been fully revised and updated to include recent developments, Biostatistics in Clinical Trials also includes up to 25% newly commissioned material reflecting the latest thinking in:
- Bayesian methods
- Benefit/risk assessment
With exceptional contributions from leading experts in academia, government and industry, Biostatistics in Clinical Trials has been designed to complement existing texts by providing extensive, up-to-date coverage and introducing the reader to the research literature.
Offering comprehensive coverage of all aspects of clinical trials Biostatistics in Clinical Trials:
- Includes concise definitions and introductions to numerous concepts found in current literature
- Discusses the software and textbooks available
- Uses extensive cross-references helping to facilitate further research and enabling the reader to locate definitions and related concepts
Biostatistics in Clinical Trials offers both academics and practitioners from various disciplines and settings, such as universities, the pharmaceutical industry and clinical research organisations, up-to-date information as well as references to assist professionals involved in the design and conduct of clinical trials.
Antibacterial Agent Trials.
Audit and Quality Control.
Binding or Masking.
Clinical Significance Versus Statistical Significance.
Clinical Trials, Overview.
Community Intervention Trials.
Controlled Clinical Trials.
Cooperative Cancer Trials.
Cooperative Heart Disease Trials.
Cooperative Studies Program, US Department of Veterans Affairs.
Covariate Imbalance, Adjustment for.
Data and Safety Monitoring.
Data and Safety Monitoring Boards.
Data Management and Coordination.
Drug Approval and Regulation.
Eligibility and Exclusion Criteria.
European Federation of Statisticians in the Pharmaceutical Industry (EFPSI).
European Organization for Research and Treatment of Cancer (EORTC).
Historical Controls, Bias From.
History, Early Cancer and Heart Disease Trials.
International Studies of Infarct Survival (ISIS).
Medical Ethics and Statistics.
Medical Research Council (MRC) Streptomycin Trial.
Noncompliance, Adjustment for.
NSABP and Advances in the Treatment of Breast Cancer.
Number Needed to Treat (NNT).
Pharmaceutical Industry, Statistics in.
Phase I Trials.
Phase II Trials.
Physicians' Health Study.
Postmarketing Surveillance of New Drugs and Assessment of Risk.
Preclinical Treatment Evaluation.
Randomized Treatment Assignment.
Sample Size Determination.
Society for Clinical Trials.
Statistical Review for Medical Journals.
Statistical Review for Medical Journals, Guidelines for Authors.
Statisticians in the Pharmaceutical Industry (PSI).
Time-varying Treatment Effect.
University Group Diabetes Program (UGDP).
"...strongly recommended as a reference for an overview of biostatistics in clinical trials..." (Statistical Methods in Medical Research, Vol.12, No.4, 2003)
"highly informative and useful book" (Journal of Tropical Paediatrics, February 2002)
"This highly informative and readable book is part of the Wiley Reference Series in Biostatistics. This book will be a useful tool for generating the required evidence and is a handy reference for the design, conduct, analysis and interpretation of clinical trials." (Journal of Tropical Pediatricstrics)
"...a valuable reference and an excellent resource to add to classroom and other teaching tools..." (Oncology, Vol.63, No.1, 2002)